Literature DB >> 11743363

The role of M2 muscarinic receptor subtypes in mediating contraction of the pig bladder base after cyclic adenosine monophosphate elevation and/or selective M3 inactivation.

Tomonori Yamanishi1, Christopher R Chapple, Kosaku Yasuda, Russell Chess-Williams.   

Abstract

PURPOSE: In the bladder body M2 muscarinic receptors predominate but a smaller population of M3 receptors mediates direct detrusor contraction. M2 receptors have an indirect role by inhibiting cyclic adenosine monophosphate mediated relaxation in the bladder body. We investigated whether a similar mechanism also exists in the bladder base.
METHODS: Experiments were performed on pig detrusor muscle. In receptor binding studies using l-quinuclidinyl [phenyl-4-(3)H] benzilate ([(3)H]QNB) (NEN Life Science Products, Inc., Boston, Massachusetts) displacement experiments were performed with subtype selective antagonists to determine the M2-to-M3 receptor ratio. In functional studies the affinity of these antagonists against carbachol induced contractions was calculated in normal tissues and in tissues after cyclic adenosine monophosphate elevation by pre-contraction with KCl and relaxation with isoprenaline, and/or selective M3 inactivation by incubation with 4-diphenylacetoxy-N-methyl-piperidine methiodide (4-DAMP) mustard (Sigma Chemical Co., St. Louis, Missouri) in the presence of methoctramine (Sigma Chemical Co.) to protect M2 receptors.
RESULTS: In saturation binding studies receptor density was 130.5 of fmol./mg. protein and the dissociation constant for [(3)H]QNB was 0.27 nM. Displacement of [(3)H]QNB by the M3 selective antagonist 4-DAMP and the M2 antagonist methoctramine indicated an M2-to-M3 ratio of about 3:1. In functional studies 4-DAMP and methoctramine caused competitive antagonism of responses with affinity values of 9.5 and 6.3 in normal tissues, and 9.3 and 6.1, respectively, in cyclic adenosine monophosphate elevated tissues, suggesting the involvement of M3 receptors only. In tissues in which M3 receptors were inactivated and cyclic adenosine monophosphate levels were elevated the affinity of 4-DAMP was significantly reduced to 8.5 but that of methoctramine was significantly increased to 6.5, suggesting the involvement of M2 receptors.
CONCLUSIONS: The M3 subtype appears to mediate contraction of the normal and cyclic adenosine monophosphate elevated tissues of the bladder base. Involvement of M2 receptors was only noted after selective M3 inactivation and cyclic adenosine monophosphate elevation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11743363

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Mirabegron: potential off target effects and uses beyond the bladder.

Authors:  Nodi Dehvari; Edilson Dantas da Silva Junior; Tore Bengtsson; Dana Sabine Hutchinson
Journal:  Br J Pharmacol       Date:  2018-01-18       Impact factor: 8.739

2.  Muscarinic regulation of neonatal rat bladder spontaneous contractions.

Authors:  Yuen-Keng Ng; William C de Groat; Hsi-Yang Wu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-05-18       Impact factor: 3.619

3.  Muscarinic receptor expression increases following exposure to intravesical pressures of < or =40 cm-H2O: a possible mechanism for pressure-induced cell proliferation.

Authors:  Sang Don Lee; Rosalia Misseri; Cem Akbal; Chaeyong Jung; Richard C Rink; Martin Kaefer
Journal:  World J Urol       Date:  2008-06-18       Impact factor: 4.226

4.  The use of occupation isoboles for analysis of a response mediated by two receptors: M2 and M3 muscarinic receptor subtype-induced mouse stomach contractions.

Authors:  Alan S Braverman; Ronald J Tallarida; Michael R Ruggieri
Journal:  J Pharmacol Exp Ther       Date:  2008-03-13       Impact factor: 4.030

5.  Comparative pharmacological analysis of Rho-kinase inhibitors and identification of molecular components of Ca2+ sensitization in the rat lower urinary tract.

Authors:  Cleber E Teixeira; Liming Jin; Fernanda B M Priviero; Zhekang Ying; R Clinton Webb
Journal:  Biochem Pharmacol       Date:  2007-06-07       Impact factor: 5.858

6.  Muscarinic receptor subtypes and signalling involved in the attenuation of isoprenaline-induced rat urinary bladder relaxation.

Authors:  Lambertus P W Witte; Noach de Haas; Mathai Mammen; Eric L Stangeland; Tod Steinfeld; Jayashree Aiyar; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

7.  Localization of peripheral autonomic neurons innervating the boar urinary bladder trigone and neurochemical features of the sympathetic component.

Authors:  L Ragionieri; M Botti; F Gazza; C Sorteni; R Chiocchetti; P Clavenzani; L Bo Minelli; R Panu
Journal:  Eur J Histochem       Date:  2013-05-06       Impact factor: 3.188

Review 8.  The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease.

Authors:  Philippa R Dale; Hana Cernecka; Martina Schmidt; Mark R Dowling; Steven J Charlton; Michael P Pieper; Martin C Michel
Journal:  Curr Opin Pharmacol       Date:  2014-03-27       Impact factor: 5.547

Review 9.  Evaluation and management of overactive bladder: strategies for optimizing care.

Authors:  Marcella G Willis-Gray; Alexis A Dieter; Elizabeth J Geller
Journal:  Res Rep Urol       Date:  2016-07-27

10.  Participation of Central Muscarinic Receptors on the Nervous Form of Chagas Disease in Mice Infected via Intracerebroventricular with Colombian Trypanosoma cruzi Strain.

Authors:  Gabriela Maira Pereira de Assis; Micheline Freire Donato; Matheus Marques Milagre; Samantha Ribeiro Béla; Mayra Fernanda Ricci; Luara Augusta Batista; Maria Elena de Lima; Fabrício de Araujo Moreira; Rosa Maria Esteves Arantes; Marta de Lana
Journal:  Pathogens       Date:  2021-01-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.